RESUMO
Objective: The aim of this study was to determine current and previous SARS-COV-2 infection, and describe risk factors associated with seropositivity, among HCWs and hospital staff between June and October of 2020. Methodology: Data from the day of enrollment for a prospective cohort study were analyzed to determine point prevalence and seroprevalence of SARS-CoV-2 infection in HCWs and hospital staff of a university hospital in Colombia. Respiratory samples were collected to perform RT-PCR tests, along with blood samples to measure SARS-CoV-2 IgM and IgG antibodies. Data on nosocomial and community risk factors for infection were also collected and analyzed. Findings: 420 HCWs and hospital staff members were included. The seroprevalence at baseline was 23.2%, of which 10.7% had only IgM antibodies, 0.7% had IgG, and 11.7% had IgM and IgG. The prevalence of acute SARS-CoV-2 infection was 1.9%. Being a nurse assistant was significantly associated with seropositivity when compared with all other job duties (PR 2.39, 95% CI 1.27-3.65, p = 0.01). Conclusions: Overall SARS-CoV-2 prevalence was 1.9% and seroprevalence was 23.15%. Nurse assistants, medical doctors or students, and laboratory workers had a higher possibility of being SARS-CoV-2 seropositive.
RESUMO
The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during pregnancy for neonatal protection against pertussis, although little is known of the protection it provides against diphtheria. The work used a cross-sectional design to estimate seroprevalence against diphtheria in 805 pregnant women with ≥37 gestation weeks and their newborns whose deliveries were attended in eight hospitals randomly chosen from a subregion of Antioquia, Colombia and to explore factors related with maternal protection. Levels of IgG antibodies were determined by using a commercial enzyme-linked immunosorbent assay test. Placental transfer of antibodies and crude and adjusted prevalence ratio (aPR) were analyzed to describe factors related with maternal protection against diphtheria. Protection against diphtheria was observed in 91.7% (95% CI 90.3-93.0) of the pregnant women and 93.1% (95% CI 91.7-94.4) of newborns, whose antibody levels were positively correlated (Spearman's r = 0.769; p = 0.000). Maternal protection could be influenced by having been vaccinated during the current pregnancy (aPR 0.85, 95% CI: 0.82-0.93). The protective effect of vaccination during pregnancy and the efficiency of maternal antibody transfers were detected. Public health efforts should focus on increasing Tdap vaccination during each pregnancy to protect mothers and newborns against diphtheria.
RESUMO
PURPOSE: This study aims to compare protection against diphtheria and tetanus conferred on the mother and the neonate before and after maternal vaccination against tetanus, diphtheria, and acellular pertussis (Tdap), transfer of antibodies, and the variables that could impact on the protection. MATERIALS AND METHODS: The study followed a cohort of 200 pregnant women from a region in Colombia, contacted during prenatal control before vaccination and upon delivery. The work determined immunoglobulin G antibodies against diphtheria and tetanus of pregnant women and umbilical cord. The proportion of protection, the geometric mean of the concentration, and the transfer of maternal antibodies were calculated. The protection profile of the pregnant women was explored by using multiple correspondence analysis. RESULTS: The concentration of antibodies against diphtheria was significant before and after vaccination of the pregnant women (p=0.000) with proportions of 85.0% and 97.5%, respectively, and of 98.6% in the umbilical cord, with significant antibody correlation (Spearman's coefficient=0.668, p=0.01). Sero-protection against tetanus before vaccination was at 71.0%, after at 92.6%, and in the umbilical cord at 95.9%, with significant antibody concentration before and after vaccination (p=0.000) and antibody correlation (Spearman's coefficient=0.936, p=0.01). Sero-protection was higher when the pregnant women were vaccine 8 to 11 weeks before delivery. Unprotected pregnant women were those not vaccinated during pregnancy. CONCLUSION: The high proportion of protection against diphtheria and tetanus and the placental transfer support the need to promote maternal immunization with Tdap.
RESUMO
INTRODUCCIÓN: La pandemia de COVID-19 surgida en China a fines de 2019, se extendió rápidamente por el mundo, con casi 600 millones de casos y 6,3 millones de fallecidos en la actualidad. Los más afectados fueron los trabajadores de la salud con al menos tres veces más riesgo que la comunidad general de contraer la enfermedad. La mayoría de los estudios sobre seroprevalencia en trabajadores de la salud, se enfocan en establecimientos de atención hospitalaria y no se ha indagado con igual intensidad sobre lo que ocurre en la Atención Primaria de Salud (APS). OBJETIVOS: Determinar prevalencia de SARS-CoV-2 mediante anticuerpos IgG en personal de atención primaria de comuna de La Pintana y explorar sus características clínicas y factores de riesgo, previo a la vacunación en Chile. METODOLOGÍA: Diseño transversal realizado en noviembre 2020. Se recogieron datos sociodemográficos y clínicos mediante entrevista cara a cara, previa firma de consentimiento. Se determinó IgG específica mediante ELISA que utiliza proteína N y S. Las diferencias entre sujetos positivos y negativos se estudiaron mediante análisis bivariado y para asociaciones encontradas, se desarrollaron modelos multivariados controlando potenciales variables de confusión. El estudio contó con la aprobación del Comité Ético Científico de la Universidad del Desarrollo. RESULTADOS: Participaron 463 funcionarios (51,4%) encontrando prevalencia de 21,8%. Los factores de riesgo fueron edad menor, ser médico y haber sido contacto estrecho de un caso. El 22% fue asintomático. Entre quienes presentan anosmia o ageusia, la probabilidad de IgG+ fue superior a 70%. Los títulos de anticuerpos aumentan significativamente con la gravedad. CONCLUSIONES: La prevalencia en personal de atención primaria encontrada es concordante con la evidencia previa en trabajadores de salud. La menor edad y la profesión de médico se asocian a un mayor riesgo de enfermar.
BACKGROUND: The COVID-19 pandemic that emerged in Wuhan, China at the end of 2019, spread rapidly around the world with almost 600 million cases and 6.3 million deaths today. The most affected were health workers with at least three times the risk of contracting the disease than the general community. Most studies on seroprevalence in health workers focus on hospital care establishments and what happens in Primary Health Care (PHC) has not been investigated with the same intensity. AIM: To determine the prevalence of SARS-CoV-2 using IgG antibodies in primary health care personnel in La Pintana commune, risk factors and clinical characteristics, prior to vaccination in Chile. METHODS: A cross-sectional design carried out in November 2020. Sociodemographic and clinical data were collected through face-to-face interviews, after providing informed consent. Specific IgG was determined by ELISA using N and S proteins. The differences between positive and negative subjects were studied using bivariate analysis and multivariate models, controlling for potential confounding variables. The study was approved by the Universidad del Desarrollo Scientific Ethics Committee. RESULTS: 463 employees (51.4%) participated, finding a prevalence of 21.8%. The risk factors found were younger age, being a physician and having been in close contact with a case. 22% were asymptomatic. Among those with anosmia/ageusia, the probability of IgG+ was greater than 70%. Antibody titers increase with severity. CONCLUSIONS: Prevalence found in primary health care personnel is consistent with previous evidence. Younger age and medical profession are associated with a higher risk of illness.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Atenção Primária à Saúde , Imunoglobulina G/análise , Pessoal de Saúde , COVID-19/epidemiologia , Ensaio de Imunoadsorção Enzimática , Estudos Soroepidemiológicos , Chile/epidemiologia , Prevalência , Estudos Transversais , Inquéritos e Questionários , Fatores de Risco , SARS-CoV-2/imunologia , COVID-19/imunologia , Anticorpos AntiviraisRESUMO
This study aimed to identify the seroprevalence of chikungunya and its associated factors in the city of Quixadá, Ceará, Brazil. We also aimed to identify the spatial distribution patterns of positive cases. A cross-sectional survey was conducted with a questionnaire about clinical symptoms, socioeconomic and demographic factors, and a 10 ml blood sample was collected and analysed by ELISA. For the bivariate analysis, we use the chi-square test, a prevalence ratio and its 95% confidence interval. A robust Poisson hierarchical regression was used to adjust for confounders. The Kernel density was performed for the spatial analysis. A total of 409 samples were analysed; of them, 70.7% were seropositive for previous exposure to chikungunya virus (CHIKV). High seropositivity for CHIKV was higher in female participants (75.5%; PR = 1.23; 95% CI: 1.06-1.43), those aged 31 years or more (74.3%; PR = 1.62; 95% CI: 1.04-2.52), and those with elementary education level (75.0%; PR = 1.30; 95% CI: 1.06-1.60). There were also high seroprevalence in those with less than a minimum wage per month (89.5%; PR = 1.59; 95% CI: 1.11-2.30), housewives (87.5%; PR = 1.64; 95% CI: 1.24-2.18) and unemployed (80.0%; PR = 1.50; 95% CI: 1.10-2.06). After adjusting for age, morning stiffness was the only chikungunya symptom that remained associated (PR = 1.20; 95% CI: 1.06-1.37; p < .001). There was an area of high density of cases in the downtown and two areas of medium density in nearby regions. Otherwise, the higher seroprevalence rates were in the peripherical neighbourhoods. There is a hyperendemicity of CHIKV in Quixadá, and most cases are spatially contiguous. The main associated clinical sign is morning stiffness, but other factors such as low income and spending a longer time at home were significantly associated with higher seroprevalence.
Assuntos
Arbovírus , Febre de Chikungunya , Animais , Anticorpos Antivirais , Brasil/epidemiologia , Febre de Chikungunya/epidemiologia , Febre de Chikungunya/veterinária , Estudos Transversais , Feminino , Humanos , Estudos Soroepidemiológicos , Inquéritos e QuestionáriosRESUMO
We estimate the seroprevalence of IgG antibodies to varicella zoster virus (VZV) based on the first serological study in a cohort of pregnant women and newborns from the Aburrá Valley (Antioquia-Colombia) who attended delivery in eight randomly chosen hospitals. An indirect enzyme immunoassay was used to determine anti-VZV IgG antibodies. Generalized linear models were constructed to identify variables that modify seropositivity. In pregnant women, seropositivity was 85.8% (95% CI: 83.4-85.9), seronegativity was 12.6% (95% CI: 10.8-14.6), and concordance with umbilical cord titers was 90.0% (95% CI: 89-91). The seropositivity of pregnant women was lower in those who lived in rural areas (IRR: 0.4, 95% CI: 0.2-0.7), belonged to the high socioeconomic status (IRR: 0.4, 95% CI: 0.2-0.7), and had studied 11 years or more (IRR: 0.6, 95% CI: 0.4-0.8). Among newborns, seropositivity was lower in those who weighed less than 3000 g (IRR: 0.8, 95% CI: 0.6-1.0). The high seropositivity and seronegativity pattern indicates the urgent need to design preconception consultation and vaccination reinforcement for women of childbearing age according to their sociodemographic conditions, to prevent infection and complications in the mother and newborn.
RESUMO
INTRODUCTION: Serological surveillance (serosurveillance) provides the most direct measure of herd immunity of vaccine-preventable diseases. Little is known about the opportunities and challenges of serosurveillance experiences, particularly pertussis. OBJECTIVE: To describe the process of serosurveillance for vaccine-preventable diseases with an emphasis on the experience of pertussis in the metropolitan area of Antioquia (Valle de Aburrá) in 2015 and 2016 and analyze the contributions and challenges for its sustainability. MATERIALS AND METHODS: We described the planning and conduction of serosurveillance of pertussis antibodies of mothers and in the umbilical cord at the time of delivery in eight hospitals based on random sampling and their capacity to advance the serosurveillance periodically. We compared the contributions and the challenges of this experience with other probabilistic and non-probabilistic programs. RESULTS: We achieved the participation of hospitals and mothers respecting the delivery care process. We established a serum bank following ethical and technical guidelines. This program based on the random selection of hospitals and mothers has enabled the estimation of antibodies prevalence in mothers and in the umbilical cord, which has been possible given the high coverage of hospital care during childbirth at a lower cost and fewer risks than a population-based survey in conflictive areas. The main challenges for the sustainability of this program are the creation of stable jobs and access to funding and legal and methodological long-term frameworks. CONCLUSIONS: Hospital serosurveillance as described is an option to monitor the impact of vaccination on the population. Our experience could be reproduced in other regions under similar conditions if the above-mentioned challenges are solved.
Introducción. La vigilancia serológica es la forma más directa de medir la inmunidad de rebaño frente a las enfermedades prevenibles por vacunación. Poco se sabe acerca de las oportunidades y los desafíos de las experiencias de serovigilancia, en general y, específicamente, la de la tosferina.Objetivo. Describir el proceso de serovigilancia de enfermedades prevenibles por vacunación con énfasis en la experiencia en el caso de la tosferina en el área metropolitana de Antioquia (Valle de Aburrá) en el 2015 y el 2016 y analizar lo que dicha experiencia ha aportado y los desafíos que persisten para su sostenibilidad.Materiales y métodos. Se describió el proceso de planeación y el desarrollo de la serovigilancia de tosferina en el momento del parto en ocho hospitales seleccionados al azar, así como la capacidad para adelantar el programa de manera periódica. Se compararon los aportes y los desafíos en el curso de esta experiencia con los de otros programas poblacionales probabilistas e institucionales no probabilistas.Resultados. Se logró la participación de los hospitales y de las madres con pleno respeto del proceso de atención del parto, y se conformó un banco de sueros siguiendo lineamientos éticos y técnicos. El programa permitió estimar la prevalencia de anticuerpos en la madre y en el cordón umbilical, lo que se facilitó por la alta cobertura de atención hospitalaria del parto, a un menor costo y menos riesgos que los programas poblacionales en zonas conflictivas. Los principales desafíos para la sostenibilidad del programa son la estabilidad laboral del personal de salud, así como normas y una financiación de largo plazo.Conclusiones. La serovigilancia hospitalaria es una opción para monitorizar el impacto poblacional de la vacunación. Esta experiencia se podría extender a otras regiones en condiciones similares si se resuelven los retos mencionados.
Assuntos
Vigilância da População , Doenças Preveníveis por Vacina/epidemiologia , Coqueluche/epidemiologia , Anticorpos Antibacterianos/sangue , Bordetella pertussis/imunologia , Colômbia/epidemiologia , Feminino , Sangue Fetal/imunologia , Humanos , Imunidade Coletiva , Recém-Nascido , Modelos Estatísticos , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/imunologia , Estudos de Amostragem , Estudos Soroepidemiológicos , População Urbana , Cobertura Vacinal , Doenças Preveníveis por Vacina/sangue , Doenças Preveníveis por Vacina/prevenção & controle , Coqueluche/sangue , Coqueluche/prevenção & controleRESUMO
Abstract Introduction: Serological surveillance (serosurveillance) provides the most direct measure of herd immunity of vaccine-preventable diseases. Little is known about the opportunities and challenges of serosurveillance experiences, particularly pertussis. Objective: To describe the process of serosurveillance for vaccine-preventable diseases with an emphasis on the experience of pertussis in the metropolitan area of Antioquia (Valle de Aburrá) in 2015 and 2016 and analyze the contributions and challenges for its sustainability. Materials and methods: We described the planning and conduction of serosurveillance of pertussis antibodies of mothers and in the umbilical cord at the time of delivery in eight hospitals based on random sampling and their capacity to advance the serosurveillance periodically. We compared the contributions and the challenges of this experience with other probabilistic and non-probabilistic programs. Results: We achieved the participation of hospitals and mothers respecting the delivery care process. We established a serum bank following ethical and technical guidelines. This program based on the random selection of hospitals and mothers has enabled the estimation of antibodies prevalence in mothers and in the umbilical cord, which has been possible given the high coverage of hospital care during childbirth at a lower cost and fewer risks than a population-based survey in conflictive areas. The main challenges for the sustainability of this program are the creation of stable jobs and access to funding and legal and methodological long-term frameworks. Conclusions: Hospital serosurveillance as described is an option to monitor the impact of vaccination on the population. Our experience could be reproduced in other regions under similar conditions if the above-mentioned challenges are solved.
Resumen Introducción. La vigilancia serológica es la forma más directa de medir la inmunidad de rebaño frente a las enfermedades prevenibles por vacunación. Poco se sabe acerca de las oportunidades y los desafíos de las experiencias de serovigilancia, en general y, específicamente, la de la tosferina. Objetivo. Describir el proceso de serovigilancia de enfermedades prevenibles por vacunación con énfasis en la experiencia en el caso de la tosferina en el área metropolitana de Antioquia (Valle de Aburrá) en el 2015 y el 2016 y analizar lo que dicha experiencia ha aportado y los desafíos que persisten para su sostenibilidad. Materiales y métodos. Se describió el proceso de planeación y el desarrollo de la serovigilancia de tosferina en el momento del parto en ocho hospitales seleccionados al azar, así como la capacidad para adelantar el programa de manera periódica. Se compararon los aportes y los desafíos en el curso de esta experiencia con los de otros programas poblacionales probabilistas e institucionales no probabilistas. Resultados. Se logró la participación de los hospitales y de las madres con pleno respeto del proceso de atención del parto, y se conformó un banco de sueros siguiendo lineamientos éticos y técnicos. El programa permitió estimar la prevalencia de anticuerpos en la madre y en el cordón umbilical, lo que se facilitó por la alta cobertura de atención hospitalaria del parto, a un menor costo y menos riesgos que los programas poblacionales en zonas conflictivas. Los principales desafíos para la sostenibilidad del programa son la estabilidad laboral del personal de salud, así como normas y una financiación de largo plazo. Conclusiones. La serovigilancia hospitalaria es una opción para monitorizar el impacto poblacional de la vacunación. Esta experiencia se podría extender a otras regiones en condiciones similares si se resuelven los retos mencionados.
Assuntos
Feminino , Humanos , Recém-Nascido , Gravidez , Coqueluche/epidemiologia , Vigilância da População , Doenças Preveníveis por Vacina/epidemiologia , Complicações Infecciosas na Gravidez/imunologia , Complicações Infecciosas na Gravidez/epidemiologia , População Urbana , Bordetella pertussis/imunologia , Estudos Soroepidemiológicos , Coqueluche/sangue , Coqueluche/prevenção & controle , Estudos de Amostragem , Modelos Estatísticos , Colômbia/epidemiologia , Imunidade Coletiva , Cobertura Vacinal , Sangue Fetal/imunologia , Doenças Preveníveis por Vacina/sangue , Doenças Preveníveis por Vacina/prevenção & controle , Anticorpos Antibacterianos/sangueRESUMO
Abstract INTRODUCTION: Chagas disease (CD) affects 5.7-7.0 million individuals worldwide, and its prevalence reached 25.1% in the state of Bahia, Brazil. There is an association between the prevalence of CD, the socioeconomic status of the population, and the risk of re-emergence due to non-vectorial transmission, such as blood transfusion. This study determined the seroprevalence of T. cruzi infection among blood donors in the state of Bahia, located in northeastern Brazil, and their epidemiological profile during a 10-year period. METHODS: We performed a descriptive cross-sectional study involving a database review. Data were collected from patients with non-negative results for T. cruzi infection during a 10-year period. RESULTS: A total of 3,084 (0.62%) samples were non-negative for T. cruzi infection in an initial serological screening, and 810 (0.16%) samples were non-negative in the second screening. The correlation between infection and age (30 years or older) and between infection and lower educational level (12 years or less) in the first and second screening was statistically significant. The seroprevalence of T. cruzi infection was higher in men in the first screening. In addition, 99.52% of the municipalities of Bahia had at least one case of CD. Livramento de Nossa Senhora and Salvador presented the highest disease prevalence and recurrence, respectively. CONCLUSIONS: The seroprevalence of T. cruzi infection in these populations was lower than that found in other studies in Brazil but was comparatively higher in densely-populated areas. The demographic characteristics of our population agreed with previous studies.
Assuntos
Humanos , Masculino , Feminino , Trypanosoma cruzi/isolamento & purificação , Doadores de Sangue/estatística & dados numéricos , Doença de Chagas/epidemiologia , Fatores Socioeconômicos , Brasil/epidemiologia , Ensaio de Imunoadsorção Enzimática , Anticorpos Antiprotozoários/sangue , Estudos Soroepidemiológicos , Programas de Rastreamento/estatística & dados numéricos , Prevalência , Estudos Transversais , Doença de Chagas/sangue , Doença de Chagas/transmissão , Distribuição por Sexo , Distribuição por IdadeRESUMO
ABSTRACT Parvovirus B19 (B19V) can be transmitted by the respiratory route, vertically - from the mother to the fetus - and via blood transfusion or organ transplantation. Infection by transfusion of blood or blood products occurs due to the resistance of B19V to viral inactivation methods. Our study evaluated the presence of B19V deoxyribonucleic acid (DNA) and the prevalence of anti-B19V class G immunoglobulin (IgG) in women of childbearing age blood donors of the Federal District, Brazil. Our results demonstrated the absence of B19V DNA in these blood donors. However, the seroprevalence for anti-B19V IgG was observed in 60.7% of this population. This study provides important data of B19V circulation in the Center-West of Brazil.
RESUMO O parvovírus B19 (B19V) pode ser transmitido por via respiratória, verticalmente - da mãe para o feto - e via transfusão de sangue e transplante de órgãos. A infecção por transfusão de sangue ou hemoderivados ocorre devido à resistência do B19V aos métodos de inativação viral. Nosso estudo avaliou a presença do ácido desoxirribonucleico (DNA) B19V e a prevalência de imunoglobulina da classe G (IgG) anti-B19V em mulheres em idade fértil, doadoras de sangue do Distrito Federal, Brasil. Nossos resultados demonstraram a ausência de DNA de B19V nesses doadores. No entanto, foi observada a soroprevalência de IgG anti-B19V em 60,7% dessa população. Este estudo fornece dados importantes da circulação do B19V no Centro-Oeste do Brasil.
RESUMO
BACKGROUND: Vaccinating populations against rubella aims to mitigate viral circulation and to ensure that women of childbearing age are immunized to reduce the incidence of congenital rubella syndrome. This study determined the serological statuses of pregnant women in an urban Brazilian population before and after the national rubella immunization campaign that was undertaken in 2008, and it assessed the socio-demographic factors associated with seronegativity. METHODS: Pregnant women living in Maceió, Alagoas, Brazil, who participated in a municipal prenatal screening program that involved blood tests for rubella, were assessed between June 2007 and May 2012. Socio-demographic factors associated with seronegativity were assessed, including the year of the blood test, categorized as before or after the 2008 immunization campaign, and the women's birth cohorts, the women's ethnicities, the gestational ages at the first prenatal visit, and the women's districts of residence. RESULTS: A total of 54,717 capillary blood samples were tested for rubella. The prevalence of pregnant women who were seronegative for rubella declined from 9.4% before the national immunization campaign to 2.8% after the national immunization campaign. Women were more likely to be seronegative for rubella before and after the immunization campaign if they were born between 1990 and 2000 or delayed starting prenatal care. CONCLUSIONS: The decline in the prevalence of pregnant women who were seronegative for rubella to <5% indicates that the 2008 Brazilian rubella immunization campaign was successful in Maceió.
Assuntos
Programas de Imunização , Complicações Infecciosas na Gravidez/prevenção & controle , Síndrome da Rubéola Congênita/prevenção & controle , Vacina contra Rubéola/administração & dosagem , Rubéola (Sarampo Alemão)/prevenção & controle , Adolescente , Adulto , Anticorpos Antivirais/sangue , Brasil , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Cuidado Pré-Natal , Síndrome da Rubéola Congênita/epidemiologia , População Urbana , Adulto JovemRESUMO
OBJECTIVE: We related seroprevalence and outbreaks data in order to identify factors that could explain the occurrence of outbreaks despite high vaccination coverage in Medellín Colombia. METHODS: Samples from a population seroprevalence data obtained in 2009 in a random survey were analyzed. IgG levels were determined for mumps using 2 commercial tests of 2119 individuals aged 6-64 years. A comparative analysis was undertaken using age-specific mumps seroprevalence data and information of 98 epidemiological investigations of mumps outbreaks reported in 2009. RESULTS: Overall, seroprevalence was 91.6% (95% CI=89.3-93.5%). The age-specific seronegativity was 20.3% and 20.6% in age groups 11-15 years and 16-20 years respectively. Individuals aged 6-20 years were the most affected during outbreaks. In individuals born in 2003, a year after the change in the booster schedule from 10 to 5 years, the proportion of unvaccinated individuals (14%) and those who received only one dose of MMR (45%) increased substantially. On average, 23.5 days elapsed between the onset of symptoms in secondary cases and the outbreak investigation. CONCLUSION: Potential contributing factors for the occurrence of outbreaks of mumps were the relatively high prevalence of seronegativity among individuals aged 11-20 years, delays in investigation and control of outbreaks, and incomplete vaccination schedules.
Assuntos
Surtos de Doenças , Caxumba/epidemiologia , Adolescente , Adulto , Anticorpos Antivirais/sangue , Criança , Colômbia/epidemiologia , Feminino , Humanos , Esquemas de Imunização , Imunoglobulina G/sangue , Masculino , Vacina contra Sarampo-Caxumba-Rubéola/administração & dosagem , Pessoa de Meia-Idade , Prevalência , Estudos Soroepidemiológicos , Vacinação/estatística & dados numéricos , Adulto JovemRESUMO
Introducción: La vigilancia de las enfermedades transmitidas por vectores es importante para establecer medidas de control en salud pública. Las poblaciones indígenas de Córdoba viven en condiciones geoclimáticas que favorecen la presencia de vectores que podrían permitir la diseminación y aparición de hantavirosis, rickettsiosis y fiebre por el virus Chikungunya. Objetivo: Establecer la seroprevalencia de Hantavirus, Rickettsia sp. y Chikungunya en la población indígena de Tuchín, Córdoba. Materiales y métodos: Se realizó un estudio descriptivo de corte transversal en 190 individuos del resguardo indígena del municipio de Tuchín; el muestreo fue realizado entre agosto y diciembre del 2012. La detección de anticuerpos IgG contra Hantavirus se llevó a cabo con la prueba IgG DxSelectTM (Focus Technologies, EL1600G, California, EE. UU.), anticuerpos IgG contra Rickettsia sp. se determinaron por inmunofluorescencia indirecta y se realizó detección de anticuerpos IgG contra el virus Chikungunya mediante ELISA de captura (Nova-Tec, inmunodiagnostica GmbH, CHIG0590, Alemania). Resultados: De 190 sueros analizados, el 5,2% (10/190) fueron positivos para Rickettsia sp. del grupo de la fiebre manchada, para Hantavirus 7 de 87 (8%) fueron positivos y no se encontraron positivos para Chikungunya. No se encontraron diferencias significativas (p = 0,05) entre los seropositivos de Hantavirus y Rickettsia sp. para las variables género, edad y ocupación. Conclusiones: Los hallazgos demuestran exposición previa a Rickettsia sp. y a Hantavirus en la población indígena de Tuchín. Los resultados pueden ser útiles para establecer una alerta sobre estas fiebres hemorrágicas. Aunque no se hallaron seropositivos para Chikungunya, este fue el primer trabajo de vigilancia epidemiológica realizado en Colombia sobre este virus.
Introduction: Vector-borne disease surveillance is important for establishing control measuresin public health. Indigenous populations of Cordoba live in climate conditions that favor the presence of vectors that might allow the spread and emergence of hantavirus cases, rickettsial and Chikungunya fever. Objective: To establish the prevalence of Hantavirus, Rickettsia sp. and Chikungunya in theindigenous population of Tuchín, Cordoba. Materials and methods: A cross-sectional descriptive study on 190 individuals of the indigenous reservation of the municipality of Tuchín was carried out; the serum samples were collected between August and December of 2012. The following serology tests were performed: antibody IgG against Hantavirus IgG Dx Select TM (Focus Technologies, EL1600G, California, USA); indirect immunofluorescence technique for Rickettsia spotted fever group IgG and ELISA IgG antibodies against Chikungunya virus (Nova-Tec, diagnostic GmbH, CHIG0590, Germany). Results: Out of 190 analyzed sera, 5.2% (10/190) were positive for Rickettsia sp. spotted fever group, Hantavirus 7 of 87 (8.0%) and 0% for Chikungunya. Significant differences among those positive for Hantavirus and Rickettsia sp. for the variables gender, age and occupation were not found. Conclusions: The findings reveal the prevalence of Rickettsia sp. and Hantavirus in the indigenous population of Tuchín. These results are useful to establishing an alert regarding thesehemorrhagic fevers. Although no positive result for Chikungunya virus was found, this is the first epidemiological surveillance study conducted in Colombia on this virus.
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Infecções por Rickettsia , Estudos Soroepidemiológicos , Orthohantavírus , Febre de Chikungunya , Povos Indígenas , Rickettsia , Sorologia , Colômbia , Técnica Indireta de Fluorescência para Anticorpo , Monitoramento EpidemiológicoRESUMO
La brucelosis canina producida por la cepa rugosa Brucella canis, constituye un riesgo para la salud pública. Debido a que produce infertilidad en ambos sexos; en hembras: abortos tardíos, reabsorciones embrionarias, muertes embrionarias, descargas vaginales de color y olor desagradables y nacimiento de cachorros débiles; en machos: epididimitis, orquitis, atrofia testicular, anormalidades espermáticas; así como puede causar enfermedad en humanos. Mediante un estudio epidemiológico descriptivo de corte transversal y mediante el cálculo para poblaciones, se seleccionaron 62 hembras caninas adultas de diferentes áreas urbanas de Montería (Córdoba) para determinar anticuerpos contra B. canis. Se usó una prueba inmunoensayo cromatográfico de fase sólida comercial. Se elaboró una base de datos en formato Excel en la que se registraron datos anamnésicos y los resultados de laboratorio. Se empleó estadística descriptiva. La seroprevalencia de B. canis fue del 6,45%. El 88,71% de las hembras tuvo historia reproductiva normal y el 11,29% se clasificó como anormal por el reporte de abortos y reabsorciones embrionarias. El 4,84% de las hembras con historial normal fueron seroprevalentes, mientras el historial del 1,61% de las seroprevalentes para B. canis tuvo historial reproductivo anormal. La seroprevalencia determinada en hembras caninas hace pensar que se debe tener presente esta enfermedad para su correcto diagnóstico, y la presencia de serorreactores es una evidencia y un riesgo epidemiológico para la salud pública.
Canine brucellosis caused by the rough strain of Brucella canis, constitutes a risk to public health because it produces infertility in both sexes; in female it causes late-term abortions, embryo resorption, embryonic death, vaginal discharges with unpleasant colors and odors, weak newborn puppies; in males it causes epididymitis, orchitis, testicular atrophy and sperm abnormalities; it can also cause illness in humans. Through a descriptive cross section epidemiological study and by calculation for populations, 62 adult canine females of different urban areas of Montería (Córdoba) were selected to determine antibodies against B. canis, using a commercial chromatographic immunoassay test in solid phase. An Excel database format was developed in order to register anamnestic data and laboratory results. In addition, descriptive statistics was employed in this study. The results of this study show that B. canis seroprevalence was 6.45%; 88.71% of the female's reproductive histories was normal; and 11.29% were classified as abnormal by the report of abortions and embryonic resorption; 4.84% of the females with normal reproductive history were seroprevalent while 1.61% of the seroprevalent for B. canis had an abnormal reproductive history. The seroprevalence determined in females dogs suggests that this disease must be considered for its correct diagnosis and the presence of seroreactants is an evidence and an epidemiological risk for public health.
RESUMO
INTRODUCTION: Rodent-borne hantaviruses cause severe human diseases. We completed a serological survey of hantavirus infection in rural inhabitants of Turvo County, in the southern State of Santa Catarina, Brazil, in which seropositivity for hantavirus was correlated to previous disease in the participants. METHODS: The levels of IgG antibodies to hantavirus Araraquara in the sera of 257 individuals were determined using an immunoenzymatic assay. RESULTS: IgG antibodies to hantavirus were found in 2.3 percent of the participants. All seropositive participants reported previous disease with symptoms suggestive of hantavirus cardiopulmonary syndrome. CONCLUSIONS: Human infections causing unreported cardiopulmonary syndrome probably occur in the southern State of Santa Catarina.
INTRODUÇÃO: Hantaviroses são zoonoses de roedores silvestres que causam doenças graves em seres humanos. Este trabalho mostra inquérito sorológico para hantavírus em população rural e periurbana do município de Turvo, Estado de Santa Catarina e a correlação da presença de anticorpos anti-hantavírus com a história mórbida pregressa dos indivíduos. MÉTODOS: Investigaram-se os 257 participantes do estudo quanto à presença de anticorpos IgG séricos anti-hantavírus Araraquara, por método imunoenzimático. RESULTADOS: A prevalência de anticorpos anti-hantavírus na população foi de 2,3 por cento. Os soropositivos possuíam antecedente nosológico sugestivo de hantavirose pregressa. CONCLUSÕES: Os achados mostram a ocorrência de infecções por hantavírus no extremo sul de Santa Catarina.
Assuntos
Adulto , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Anticorpos Antivirais/sangue , Infecções por Hantavirus/epidemiologia , Orthohantavírus/imunologia , Imunoglobulina G/sangue , Brasil/epidemiologia , Ensaio de Imunoadsorção Enzimática , Infecções por Hantavirus/diagnóstico , Prevalência , População RuralRESUMO
The geographic distribution of paracoccidioidomycosis (PCM) in the Brazilian state of São Paulo was evaluated in a retrospective study using secondary data from serological analyses, carried out by double immunodiffusion assay of patients with PCM suspicion, from January 1999 to May 2010. Sixty percent of 10,176 patients, from 239 cities, were serologically reactive to P. brasiliensis. The cities that showed the most serological reactivity among patients were São João da Boa Vista (85%), Piracicaba (75%), Sorocaba (73%), Campinas (72%) and São Paulo (62%). São Paulo state has an area of 248,209.4 km²; the climate is tropical and sub-tropical with annual temperatures between 18 and 24ºC, high rainfall (900 to 1800 mm/year), rainy summers and mild winters. It also features large areas composed of acidic soils, and is one of the greatest contributors to Brazilian agricultural production and, separately, the largest producer of orange juice and, the ninth greatest producer of soy and sugar cane and the fourth largest coffee producer. We suggest that the climatic characteristics associated with soil type and development of primary activities can contribute to the endemic potential of PCM in São Paulo state.
Assuntos
Humanos , Masculino , Feminino , Paracoccidioides/imunologia , Paracoccidioidomicose/epidemiologia , Estudos EpidemiológicosRESUMO
The geographic distribution of paracoccidioidomycosis (PCM) in the Brazilian state of São Paulo was evaluated in a retrospective study using secondary data from serological analyses, carried out by double immunodiffusion assay of patients with PCM suspicion, from January 1999 to May 2010. Sixty percent of 10,176 patients, from 239 cities, were serologically reactive to P. brasiliensis. The cities that showed the most serological reactivity among patients were São João da Boa Vista (85%), Piracicaba (75%), Sorocaba (73%), Campinas (72%) and São Paulo (62%). São Paulo state has an area of 248,209.4 km²; the climate is tropical and sub-tropical with annual temperatures between 18 and 24ºC, high rainfall (900 to 1800 mm/year), rainy summers and mild winters. It also features large areas composed of acidic soils, and is one of the greatest contributors to Brazilian agricultural production and, separately, the largest producer of orange juice and, the ninth greatest producer of soy and sugar cane and the fourth largest coffee producer. We suggest that the climatic characteristics associated with soil type and development of primary activities can contribute to the endemic potential of PCM in São Paulo state.(AU)
Assuntos
Humanos , Animais , Paracoccidioides/patogenicidade , Paracoccidioidomicose/epidemiologia , Testes Sorológicos/estatística & dados numéricos , Testes Imunológicos/estatística & dados numéricosRESUMO
OBJETIVO: Determinar el estado actual de la seroprevalencia de la enfermedad de Chagas en la población del cantón Aguarico, y comparar los resultados obtenidos con datos provenientes de otros estudios epidemiológicos. MÉTODOS: Desde septiembre de 2008 hasta octubre de 2009 se recogieron 2 033 sueros correspondientes a 36,6 por ciento de la población total del cantón Aguarico. Se empleó la técnica CHAGATEST/ELISA recombinante v.3.0 para determinar positividad a la enfermedad de Chagas. Los casos positivos se confirmaron con pruebas de hemoaglutinación indirecta y ELISA. RESULTADOS: De las 2 033 muestras de suero obtenidas, 73 fueron positivas para Chagas (3,6 por ciento). El rango de variación de seroprevalencia en las comunidades con casos positivos osciló entre 1,4 por ciento y 13,3 por ciento. Un 60,3 por ciento de los casos positivos se encontraron en el sexo femenino. Estos hallazgos son similares a los de estudios previos de comparación realizados en 1990. CONCLUSIONES: Los datos obtenidos confirman la existencia de un foco autóctono de la enfermedad de Chagas en la Amazonía ecuatoriana, con un porcentaje superior a la media de la región amazónica. No se detectaron cuadros clínicos agudos ni patologías crónicas. Es perentorio implementar un programa de control de la enfermedad culturalmente adaptado a la región.
OBJECTIVE: Determine the current seroprevalence of Chagas disease in the population of Aguarico canton, and compare the findings with data from other epidemiological studies. METHODS: From September 2008 to October 2009, 2 033 serum samples were collected from 36.6 percent of the total population in Aguarico canton. The Chagatest recombinant ELISA v.3.0 was used to determine positivity to Chagas disease. Cases that tested positive were confirmed by indirect hemagglutination and ELISA. RESULTS: Of the 2 033 serum samples obtained, 73 tested positive for Chagas disease (3.6 percent). Seroprevalence in communities with positive cases ranged from 1.4 percent to 13.3 percent, with 60.3 percent of the positive cases found in females. These findings are similar to the 1990 comparison studies. CONCLUSIONS: The data obtained confirm the existence of an indigenous focus of Chagas disease in the Ecuadorian Amazon, with a percentage higher that the average for the Amazon region. No acute clinical cases or chronic pathologies were detected. Implementation of a culturally appropriate Chagas control program for the region is urgently needed.